Table 1. Characteristics of 1088 HIV positive pregnant women at enrollment in the Tingathe program.
Characteristic | Result | |
Age, mean years (SD) | 27.8 (5.2) | |
Trimester of pregnancy: n(%) | ||
First | 54 (5.0) | |
Second | 645 (59.3) | |
Third | 384 (35.3) | |
Missing data | 5 (0.4) | |
HIV status at enrollment, n (%) | ||
Newly diagnosed as HIV-infected | 780 (71.7) | |
Already known to be HIV-infected | 308 (28.3) | |
ART eligibility at enrollment | ||
On ART | 262 (24.1) | |
Eligible but not on ART | 307 (28.2) | |
Not Eligible | 496 (45.6) | |
Missing data | 23 (2.1) | |
CD4+ cells/mm3 at PMTCT entry for women not already on ART, n/N (%) a | ||
≤ 250 | 192 (17.6) | |
251–349 | 149 (13.7) | |
350–499 | 224 (20.6) | |
≥500 | 238 (21.8) | |
Missing data | 23 (2.1) | |
Partner Disclosure status at enrollment, n (%) b | ||
Partner involved and disclosed | 319 (29.3) | |
Partner involved, not disclosed | 708 (65.1) | |
Partner not involved | 61 (5.6) |
Of the 1088 mother-infant pairs with first DNA PCR results, 262 mothers were already on ART, 23 with no corresponding maternal CD4 results, therefore 803 available CD4 results with corresponding PCR results.
Partner disclosed defined as partner having knowledge of maternal HIV status. Partner non-involved defined as a partner who has died, or is otherwise separated from the mother.
Abbreviations: ART (antiretroviral therapy), CD4+ (CD4+ cell count), PMTCT (prevention of mother-to-child transmission).